The University of Minnesota is no Pfizer or Merck. But that doesn’t mean it shouldn’t act more like Big Pharma.The school has begun an ambitious effort to convert its considerable drug research into actual products. The idea is to better coordinate drug discovery projects among programs like the Masonic Cancer Center, medical school and College [...]

Perhaps they should rename the school the University of MGI Pharma.Reggie Bowerman, a former MGI Pharma executive, recently joined the University of Minnesota’s Office for Technology Commercialization (OTC) as head of the newly formed Life Science Business Unit.He will oversee a group responsible for advising researchers on how to develop market viable diagnostics, biologics, drugs, [...]